COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,946 Articles (22,604 medRxiv, 8,342 bioRxiv)

Most recent first Previous |  Page 477: Articles 4761-4770  | Next

Safety of bivalent omicron-containing mRNA-booster vaccines: a nationwide cohort study
Andersson, N. W., Thiesson, E. M., Hansen, J. V., Hviid, A.
10.1101/2023.01.21.23284855 — Posted: 2023-01-22
Electronic data review, client reminders, and expanded clinic hours for improving cervical cancer screening rates after COVID19 pandemic shutdowns: a multi-component quality improvement program
Ghosh, S., Fantes, J., Leschly, K., Mazul, J., Perkins, R. B.
10.1101/2023.01.20.23284607 — Posted: 2023-01-22
Assessing the effectiveness of portable HEPA air cleaners for reducing particulate matter exposure in King County, Washington homeless shelters during the COVID-19 pandemic: implications for community congregate settings
Huang, C.-H., Bui, T., Hwang, D., Shirai, J., Austin, E., Cohen, M., Gould, T., Larson, T., Novosselov, I., Tan, S., Seto, E.
10.1101/2023.01.20.23284493 — Posted: 2023-01-22
Overcrowded Housing Reduces COVID-19 Mitigation Measures and Lowers Emotional Health Among San Diego Refugees from September to November of 2020
Hassani, A., Omaleki, V., Erikat, J., Frost, E., Streuli, S., Sahid, R., Yusufi, H., Fielding-Miller, R. K.
10.1101/2023.01.20.23284851 — Posted: 2023-01-22
Comparative effectiveness of Paxlovid versus sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in non-hospitalised patients: observational cohort study using the OpenSAFELY platform
Zheng, B., Tazare, J., Nab, L., Mehrkar, A., MacKenna, B., Goldacre, B., Douglas, I. J., Tomlinson, L., The OpenSAFELY Collaborative
10.1101/2023.01.20.23284849 — Posted: 2023-01-22
Evaluation of Potential Adverse Events Following COVID-19 mRNA Vaccination Among Adults Aged 65 Years and Older: A Self-Controlled Study in the U.S.
Shaoibi, A., Lloyd, P. C., Wong, H.-L., Clarke, T., Chillarige, Y., Do, R., Hu, M., Jiao, Y., Kwist, A., Lindaas, A., McEvoy, R., Ondari, M., Parulekar, S., Shi, C., Wang, J., Lu, Y., Obidi, J., Zhou, C. K., Kelman, J. A., Forshee, R. A., Anderson, S. A.
10.1101/2023.01.19.23284803 — Posted: 2023-01-22
Epidemic Persistence: Equilibria and Stability Analysis of Spread Process Dynamics over Networks, with Asymptomatic Carriers and Heterogeneous Model Parameters
Bi, X., Beck, C.
10.1101/2023.01.20.23284824 — Posted: 2023-01-22
ONE ASSAY TO TEST THEM ALL: COMPARING MULTIPLEX ASSAYS FOR EXPANSION OF RESPIRATORY VIRUS SURVEILLANCE
Boukli, N., Flammand, C., Chea, K. L., Heng, L., Keo, S., Sour, K., In, S., Chhim, P., Chhor, B., Kruy, L., Feenstra, J. D. M., Gandhi, M., Okafor, O., Ulekliev, C., Auerswald, H., Horm, V. S., Karlsson, E. A.
10.1101/2023.01.19.23284806 — Posted: 2023-01-22
Whole transcriptome profiling of placental pathobiology in SARS-CoV-2 pregnancies identifies a preeclampsia-like gene signature
Stylianou, N., Sebina, I., Matigian, N., Deohler, H., Monkman, J., Rohl, J., Allenby, M., Nam, A., Pan, L., Rockstroh, A., Sadeghirad, H., Chung, K., Sobanski, T., O'Byrne, K., Rebutini, P. Z., Machado-Souza, C., Stonoga, E. T. S., Warkiani, M. E., Salomon, C., Short, K. R., McClements, L., de Noronha, L., Huang, R. Y.-J., Belz, G., Guimaraes, F., Clifton, V., Kulasinghe, A.
10.1101/2023.01.20.524893 — Posted: 2023-01-21
Frequency and Clinical Characteristics of Breakthrough Cases Post COVID-19 Vaccine and Predictive Risk Factors in College Students
Abdulrazaq, M., Jebur, A., Hamdan, B., Ibrahim, A.
10.1101/2023.01.20.23284814 — Posted: 2023-01-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).